Mersana Therapeutics, Inc. Defined Contribution Plan, Cost
Mersana Therapeutics, Inc. reported Defined Contribution Plan, Cost of $800.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2025-03-03
- Mersana Therapeutics, Inc. defined contribution plan, cost for fiscal 2024 was $800.00K, a 38.46% decline from fiscal 2023.
- Mersana Therapeutics, Inc. defined contribution plan, cost for fiscal 2023 was $1.30M, a 18.18% increase from fiscal 2022.
- Mersana Therapeutics, Inc. defined contribution plan, cost for fiscal 2022 was $1.10M, a 37.50% increase from fiscal 2021.
- Mersana Therapeutics, Inc. defined contribution plan, cost for fiscal 2021 was $800.00K, a 60.00% increase from fiscal 2020.
| Period end | Defined Contribution Plan, Cost 12 month | Defined Contribution Plan, Cost 12 month as first filed |
|---|---|---|
| 2024-12-31 | $800.00K 10-K · filed 2025-03-03 | |
| 2023-12-31 | $1.30M 10-K · filed 2025-03-03 | |
| 2022-12-31 | $1.10M 10-K · filed 2025-03-03 | |
| 2021-12-31 | $800.00K 10-K · filed 2024-02-28 | $764.00K 10-K · filed 2022-02-28 |
| 2020-12-31 | $500.00K 10-K · filed 2023-02-28 | $486.00K 10-K · filed 2021-02-26 |
| 2019-12-31 | $404.00K 10-K · filed 2022-02-28 | |
| 2018-12-31 | $332.00K 10-K · filed 2021-02-26 | |
| 2017-12-31 | $273.00K 10-K · filed 2020-02-28 | |
| 2016-12-31 | $136.00K 10-K · filed 2019-03-08 | |
| 2015-12-31 | $100.00K 10-K · filed 2018-03-28 |